Searched for
GOOD LABORATORY PRACTISE
Use of chemical fertilisers root cause of many diseases, says Amit Shah; pitches for natural farmingUnion Home Minister Amit Shah champions natural farming, calling chemical fertilizers a cause of diseases. He stated natural farming boosts...- Another mysterious virus spreading in China. WHO seeks report. Here is all you should knowThe outbreak originated in northern China, with a significant number of cases involving children. Hospitals in the affected areas are repor...
- Insecticides India gets GSP compliance certification for its Chopanki R&D labIIL managing director Rajesh Aggarwal said, "We are adding another feather to its cap, Insecticides (India) Limited (IIL), the country’s le...
- Ensure robust prevention & control practices to contain black fungus infection: Centre to statesUnion Health Secretary Rajesh Bhushan has written to the Chief Secretaries and Administrators of all states and UTs, urging them to underta...
- Indian scientists have made valuable contributions to society: Harsh VardhanThe minister recalled that a top official of the WHO had hailed the strength of India's traditional medicine, Ayurveda, the country's medic...
- Dr Reddy's gets nod to restart exports to EU from Vizag plantThe company, however, did not elaborate on the observations which were made by the regulator related to violations of good manufacturing pr...
- Fleming Lab's Nawabpet facility comes under USFDA scannerEstablished in 1995, Fleming Laboratories is in the business of manufacturing and supply of generic Active Pharmaceutical Ingredients (APIs...
- IPCA Lab tanks on USFDA import alert; m-cap down by Rs 1,205 croreDuring the day the shares of the company opened on a weak note and then tanked as much as 13.42% to touch an intra-day low of Rs 658 on the...
- US FDA issues import alert to 2 plants of IPCA LaboratoriesThe U.S. regulator had in January banned imports from a separate central Indian manufacturing plant of Ipca, citing violations of standard ...
- US FDA did not find issues with Wockhardt's Chikalthana plant"There were no findings with respect to data security and control measures in laboratory and manufacturing," Wockhardt said in a BSE filing.
- Ranbaxy loses approvals, exclusivity of two drugs in USIn November, Ranbaxy had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US.
- US based Underwriters Laboratories inks pact with Gujarat government to train FDCA inspectorsThe company has signed a memorandum of understanding (MoU) with the Gujarat government to train Gujarat Food and Drug Control Authority (FD...
- Pharma in 2014: Deals worth billions and fines worth millionsRanbaxy, founded by the family of Malvinder and Shivinder Mohan Singh, was at the centre of most of the developments for major part of the ...
- Robert Bosch-backed labs works with hospitals to create IoT applications that can work for IndiaThe laboratory is currently testing devices that can help control hospital acquired infections and detect neonatal infections.
- US FDA cites Apotex's Indian drug facility for fraudulent dataAn Indian subsidiary of Apotex manipulated laboratory data, retesting samples until the results were acceptable, according to a warning let...
- Glenmark's molecule for pain therapy entering human trialsGlenmark Pharmaceuticals said its novel chemical entity for potential treatment of chronic inflammatory disorders is entering human trials.
- USFDA raises concerns over Ranbaxy's Toansa plantThe US Food and Drug Administration's observations regarding the manufacturing practices in the company's plant in Punjab.
- Ranbaxy's US unit gets USFDA's establishment inspection reportThe US health regulator has given Ranbaxy Laboratories' American arm Ohm Laboratories Inc a report indicating closure of inspection of its ...
- No plans to reduce workforce: Ranbaxy LaboratoriesRanbaxy Laboratories has no plans to reduce its workforce and is focusing on improving performance and productivity.
- Certain consent decree terms to apply to Mohali unit: RanbaxyThe decree contains provisions to ensure CGMP (Current Good Manufacturing Practices) compliance at certain Ranbaxy facilities.
Load More
